3rd Annual Formulation & Drug Delivery USA Congress

17 - 18 March 2020, San Diego, USA

Join us at our 3rd Annual Formulation & Drug Delivery USA Congress

Over 300 delegates representing leading pharmaceutical organisations, biotech companies internationally renowned research & academic institutions will be present

Over 55 case studies and presentations focused on exploring challenges and solutions in formulation and drug delivery of small and large molecules. This includes the latest strategies for optimizing pharmaceutical formulations, new drug delivery systems including nano & RNA delivery, Quality by Design for continuous manufacturing and processing, and the bioanalysis, characterisation and stabilisation of drug products

  *Six highly interactive streams:*

·         Innovation In Large Molecule Drug Development

·         Small Molecule Drug Delivery

·         NEW! Continuous Manufacturing, CMC and Process Development

o   Featured Session: Cell & Gene Therapy Delivery 

·         Small Molecule Drug Formulation

·         Advances in Large Molecule Drug Delivery

·         NEW! Bioanalysis, Characterization & Stabilization

o   Featured Session: Nano & RNA Delivery & Formulation

  *View Agenda: https://bit.ly/33Tqvwh

Co-located with the 3rd Annual Inhalation & Respiratory Drug Delivery USA Congress.

For more information contact g.alonso@oxfordglobal.co.uk.

Go Social: Join our Formulation & Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress & join the conversation at #FDDUS19

  *2019 Live Webinars*

“Understanding Supersaturation Of Small Molecule To Improve Oral Bioavailability” 
Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research 
5th February 2020, 09.30am EST/14.30pm UK Time.
  *Register for Free: https://bit.ly/2jW6Ev9

“Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development”
Hovik Gukasyan, Associate Director, Early Development Formulation and Physical Chemistry, Allergan
12th February 2020, 08.00am EST/16.00pm UK Time. 
  *Register for Free: https://bit.ly/2ls6Y5j*

Kerstin Walke, Vice President of Pharmaceutical Development, Boehringer Ingelheim

Anand Subramony, Vice President, External Innovation and Novel Technologies, AstraZeneca

Sushrut Kulkarni, Group Vice President – Formulation & CMC, Glenmark Pharmaceuticals

Marian Gindy, Executive Director, Pharmaceutical Sciences, MSD

Evgenyi Shalaev, Executive Director, Pharmaceutical Development, Allergan

Parag Kolhe, Senior Director, Pharmaceutical Research & Developmen,
Pfizer

Satoshi Ohtake, Senior Director of Pharmaceutical Research & Development, Pfizer

Plus many more!